The ESOT Congress serves as a premier platform for researchers from across the globe to present their organ transplantation research, the abstract submission is open, with the following key submission deadlines: Abstract submission: 22 February 2021 Late-breaking abstract submission period: 10-25 May 2021 (preliminary research must be provided by 22 February 2021) Find out more by reading our abstract and clinical
Category: Intestine
ESOT Leonardo Da Vinci Transplant Research Innovation Award
This is the most prestigious scientific award at the ESOT Congress, stimulating an unprecedented and innovative approach to research. There are two winners of this award; one for ???????????????????????????????? ???????????????????????????????? and one for ???????????????????? ???????? ???????????????????????????????????????????????????? ????????????????????????????. Prior to the congress, eight outstanding contributions are selected from all of the scientific abstracts submitted to the
Transplant International names new Editor-in-Chief for 2021-2025
ESOT is delighted to announce the appointment of Prof. Thierry Berney as the new Editor-in-Chief for Transplant International. Prof. Berney is a Past President of ESOT, an Associate Editor of TI and a full professor at the Department of Surgery of the University of Geneva School of Medicine. He will lead the new editorial team
ESOT Transplant Fellowship 2021 – Application deadline 15|10|2020
We are pleased to announce the ESOT Grants Programme for 2021! The application deadline is October 15th 2020.
Join our dedicated COVID-19 Open Forum
At this challenging time ESOT has created a dedicated online forum for transplant professionals to discuss experiences, offer recommendations and share resources linked to COVID-19. The forum is FREE of charge and open to all transplant professionals. Now, more than ever, we are #StrongerTogether. JOIN THE COVID-19 DISCUSSION ESOT Transplant Live subscribers can access the forum using their
COVID-19 Response ELITA-ELTR registry and studies
The COVID-19 pandemic brought transplantation to a global standstill. Since February, 2020, healthcare providers implemented a radical and focused response to the pandemic, prioritizing organizational readiness and resource re-allocation to meet the anticipated influx of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Many services, including solid organ transplantation, were suspended as intensive